PTC THERAPEUTICS, INC. (PTCT) › Shareholders' EquityPTC THERAPEUTICS, INC. (PTCT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: -$272.33M2011: -$238.60M2012: -$99.64M2013: $136.54M2014: $298.47M2015: $226.00M2016: $119.58M2017: $156.44M2018: $350.73M2019: $594.33M2020: $481.98M2021: $1.44M2022: -$347.09M2023: -$818.55M2024: -$1.10B2025: -$205.31M-$205.31M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$205.31M+81.3%2024-$1.10B-34.1%2023-$818.55M-135.8%2022-$347.09M-24236.7%2021$1.44M-99.7%2020$481.98M-18.9%2019$594.33M+69.5%2018$350.73M+124.2%2017$156.44M+30.8%2016$119.58M-47.1%2015$226.00M-24.3%2014$298.47M+118.6%2013$136.54M+237.0%2012-$99.64M+58.2%2011-$238.60M+12.4%2010-$272.33M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share